Improving metabolic stability of cancer chemoprotective polyphenols

Thomas Walle1, Xia Wen, U Kristina Walle

  • 1Medical University of South Carolina, Department of Cell and Molecular Pharmacology and Experimental Therapeutics, 173 Ashley Avenue, Charleston, SC 29425, USA. wallet@musc.edu

Insights

Dietary polyphenols show promise for cancer prevention but suffer from poor bioavailability. Permethylation enhances their absorption and stability, suggesting a future for these modified compounds as chemoprotective agents.

Area of Science:

  • Nutritional biochemistry
  • Pharmacology
  • Cancer chemoprevention

Background:

  • Dietary flavonoids and polyphenols offer potential therapeutic benefits for cancer and other diseases.
  • Poor oral bioavailability, primarily due to glucuronidation and sulfation, significantly limits their efficacy.
  • Developing strategies to enhance polyphenol bioavailability is crucial for their therapeutic application.

Purpose of the Study:

  • To assess the metabolic stability of polyphenols using a human hepatic S9 fraction model.
  • To investigate the impact of permethylation on polyphenol bioavailability and biological activity.
  • To evaluate the potential of permethylated polyphenols as chemoprotective agents.

Main Methods:

  • Utilized a commercially available human hepatic S9 fraction to assess metabolic stability.
  • Employed permethylation to block metabolic conjugation pathways of polyphenols.
  • Evaluated changes in metabolic stability and intestinal absorption post-permethylation.

Main Results:

  • The human hepatic S9 fraction provided an effective and accurate method for assessing metabolic stability.
  • Permethylation significantly increased the metabolic stability and intestinal absorption of polyphenols.
  • Biological activities were maintained or enhanced after permethylation.

Conclusions:

  • Permethylated polyphenols demonstrate improved bioavailability and metabolic stability.
  • This modification strategy holds promise for overcoming the limitations of natural polyphenols.
  • Permethylated polyphenols represent a potential future for chemoprotective agents in disease prevention and treatment.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...